Einstein Experts
Nir Barzilai, M.D.
Professor, Medicine (Endocrinology)
Director, Institute for Aging Research
Director, Nathan Shock Center of Excellence in the Basic Biology of Aging
Ingeborg and Ira Leon Rennert Chair of Aging Research
AgingBiology of agingLongevity genes
Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times, PBS’ “NOVA scienceNow” and National Geographic.
Treatments for age-related diseases like type 2 diabetes are being developed based on Dr. Barzilai’s work and are currently in clinical trials. In addition to his “longevity gene” research, Dr. Barzilai studies key mechanisms involved in the biology of aging, including how nutrients and genetics influence lifespan. He is also investigating the physical and mental declines associated with aging and how they affect longevity. Dr. Barzilai is professor of medicine (endocrinology) and of genetics, a member of the Diabetes Research Center and director of the Diabetes Research and Training Center’s Animal Physiology core.
Highlighted Media Coverage
Einstein Multimedia
Unlocking the Secrets of Longevity: 20 Year Anniversary of Aging Research at Einstein
Science Talk: Lifestyles Of The Old And Healthy Defy Convention
Science Talk: "Personality Genes" May Help Account for Longevity
Aging Research: Is There A Longevity Gene?
Professional Links
Tag Cloud
arthritis cancer alzheimer's disease/dementia prenatal testing diabetes genetics stem cell research gene therapy cell therapy liver diseases type 2 diabetes global health bioethics nutrition obesity aging hypertension cardiovascular disease diabetes prevention clinical trials lupus autoimmune diseases translational medicine infectious diseases tuberculosis (tb) type 1 diabetes autism translational research biochemistry biomedical technologies breast cancer